GROWTH FACTOR RECEPTOR SIGNAL TRANSDUCTION

生长因子受体信号传导

基本信息

项目摘要

This proposed research program builds upon and significantly expands our currently funded Program Project which has successfully integrated complementary scientific thrusts to study growth factor receptor-mediated signal transduction mechanisms in normal and malignant cells. In this proposed Program, seven carefully integrated projects with the support of four core facilities will utilize a variety of model systems to test hypotheses about cellular signalling pathways at the plasma membrane, cytoplasmic, and nuclear levels. Projects 1 (R. Davis) and 2 (H. Robinson and D. Gamett) will seek to identify regulated phosphorylation sites on the EGF receptor and erb B proteins and to evaluate their role in modulating receptor function and erb B disease potential. Project 3 (M. Czech and J. Klarlund) will test the hypothesis that tyrosine phosphorylation of a multi-subunit serine kinase, casein kinase II, activates this latter enzyme as part of a major signalling phosphorylation cascade for receptor and oncogene tyrosine kinases. Project 4 (G. Johnson) seeks to define the function of specific G proteins in growth factor receptor signalling events using in vitro mutagenesis and expression of cDNA for Gi alpha proteins. This study will assess interactions of expressed alpha subunits with other G protein subunits and their role in mediating metabolic responses to growth factors. Project 5 (F. Fay) will explore mechanisms that underly growth factor- mediated chemotactic responses by analysis of local changes in intracellular calcium and (H+) using computer-based image intensification of fluorescence signals in neutrophils. Projects 6 (J. Massague) and 7 (J. and G. and G. Stein) involve efforts of two groups toward defining the molecular basis of TGF-beta action. Project 6 will focus on the mechanisms by which TGF-beta modulate expression and function of cell surface receptors for extracellular matrix molecules (integrins). Project 7 will seek to identify specific genes which are differentially expressed in the presence and absence to TGF-beta and which are involved in regulating 3T3- L1 cell differentiation. Four core facilities will provide support, instrumentation, technology and reagents for the above integrated efforts by making available (1.) media and technical time for tissue culture, (2.) peptide synthesis, (3.) cell science technology including immunohistology and micromanipulations and, (4.) recombinant DNA techniques and reagents. Core facilities will be directed by established investigators with extensive experience and training in the areas of expertise provided by each core.
这个拟议的研究计划建立在

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL P CZECH其他文献

MICHAEL P CZECH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL P CZECH', 18)}}的其他基金

CRISPR-enhanced adipocyte browning to improve glucose tolerance in obesity and diabetes
CRISPR 增强脂肪细胞褐变以改善肥胖和糖尿病的葡萄糖耐量
  • 批准号:
    10335608
  • 财政年份:
    2021
  • 资助金额:
    $ 76.05万
  • 项目类别:
CRISPR-enhanced adipocyte browning to improve glucose tolerance in obesity and diabetes
CRISPR 增强脂肪细胞褐变以改善肥胖和糖尿病的葡萄糖耐量
  • 批准号:
    10649531
  • 财政年份:
    2021
  • 资助金额:
    $ 76.05万
  • 项目类别:
CRISPR-enhanced adipocyte browning to improve glucose tolerance in obesity and diabetes
CRISPR 增强脂肪细胞褐变以改善肥胖和糖尿病的葡萄糖耐量
  • 批准号:
    10490350
  • 财政年份:
    2021
  • 资助金额:
    $ 76.05万
  • 项目类别:
Adipocyte to neuron signaling in thermogenic programming of white adipose tissue
白色脂肪组织产热编程中的脂肪细胞至神经元信号传导
  • 批准号:
    10547782
  • 财政年份:
    2019
  • 资助金额:
    $ 76.05万
  • 项目类别:
Adipocyte to neuron signaling in thermogenic programming of white adipose tissue
白色脂肪组织产热编程中的脂肪细胞至神经元信号传导
  • 批准号:
    9889952
  • 财政年份:
    2019
  • 资助金额:
    $ 76.05万
  • 项目类别:
Adipocyte to neuron signaling in thermogenic programming of white adipose tissue
白色脂肪组织产热编程中的脂肪细胞至神经元信号传导
  • 批准号:
    10341100
  • 财政年份:
    2019
  • 资助金额:
    $ 76.05万
  • 项目类别:
Adipocyte to neuron signaling in thermogenic programming of white adipose tissue
白色脂肪组织产热编程中的脂肪细胞至神经元信号传导
  • 批准号:
    10087919
  • 财政年份:
    2019
  • 资助金额:
    $ 76.05万
  • 项目类别:
Insulin Signaling and Metabolic Regulation in Adipocytes
脂肪细胞中的胰岛素信号传导和代谢调节
  • 批准号:
    10194465
  • 财政年份:
    2017
  • 资助金额:
    $ 76.05万
  • 项目类别:
Paracrine Signaling by Kupffer Cells in Hepatic Insulin Resistance
肝胰岛素抵抗中库普弗细胞的旁分泌信号传导
  • 批准号:
    8888443
  • 财政年份:
    2015
  • 资助金额:
    $ 76.05万
  • 项目类别:
Paracrine Signaling by Kupffer Cells in Hepatic Insulin Resistance
肝胰岛素抵抗中库普弗细胞的旁分泌信号传导
  • 批准号:
    9029321
  • 财政年份:
    2015
  • 资助金额:
    $ 76.05万
  • 项目类别:

相似海外基金

EXPANSION AND GENETIC TRANSDUCTION OF EBV-SPECIFIC CTLS
EBV 特异性 CTLS 的扩增和遗传转导
  • 批准号:
    2867484
  • 财政年份:
    1999
  • 资助金额:
    $ 76.05万
  • 项目类别:
Genetic Transduction by Bacteriophage
噬菌体基因转导
  • 批准号:
    5601590
  • 财政年份:
    1956
  • 资助金额:
    $ 76.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了